SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    The French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 2531.
  • 2
    The International FMF Consortium. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797807.
  • 3
    Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 1967; 43: 22753.
  • 4
    Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 187985.
  • 5
    Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW. Colchicine therapy for familial Mediterranean fever: a double-blind trial. N Engl J Med 1974; 291: 9347.
  • 6
    Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, et al. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. N Engl J Med 1974; 291: 9324.
  • 7
    Zemer D, Pras M, Sohar E, Modan M, Cabili S, Gafni J. Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Engl J Med 1986; 314: 10015.
  • 8
    Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Geneviève D, Mndjoyan E, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000; 67: 113643.
  • 9
    Cazeneuve C, Sarkisian T, Pêcheux C, Dervichian M, Nédelec B, Reinert P, et al. MEFV-gene analysis in Armenian patients with familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype—genetic and therapeutic implications. Am J Hum Genet 1999; 65: 8897.
  • 10
    Cotton RG. Slowly but surely toward better scanning for mutations. Trends Genet 1997; 13: 436.
  • 11
    Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, et al. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 1999; 6: 16.
  • 12
    Akar N, Misiroglu M, Yalcinkaya F, Akar E, Cakar N, Tümer N, et al. MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Hum Mutat 2000; 15: 11899.
  • 13
    Shinawi M, Brik R, Berant M, Kasinetz L, Gershoni-Baruch R. Familial Mediterranean fever: high gene frequency and heterogeneous disease among an Israeli-Arab population. J Rheumatol 2000; 27: 14925.
  • 14
    Schollen E, Kjaergaard S, Legius E, Schwartz M, Matthijs G. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia). Eur J Hum Genet 2000; 8: 36771.
  • 15
    Akarsu A, Saatci U, Ozen S, Bakkaloglu A, Besbas N, Sarfarazi M. Genetic linkage study of familial Mediterranean fever (FMF) to 16p13.3 and evidence for genetic heterogeneity in the Turkish population. J Med Genet 1997; 34: 5738.
  • 16
    Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu R, Besbas N, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9: 5535.
  • 17
    Aksentijevich I, Torosyan Y, Samuels J, Centola M, Pras E, Chae JJ, et al. Mutations and haplotype studies of familial Mediterranean fever reveal new ancestral relationships and evidence for a high carrier frequency with reduced penetrance in the Ashkenazi Jewish population. Am J Hum Genet 1999; 64: 94962.
  • 18
    Gershoni-Baruch R, Shinawi M, Leah K, Badarnah K, Brik R. Familial Mediterranean fever: prevalence, penetrance and genetic drift. Eur J Hum Genet 2001; 9: 6347.
  • 19
    Gershoni-Baruch R, Shinawi M, Shamaly H, Katsinetz L, Brik R. Familial Mediterranean fever: the segregation of 4 different mutations in 13 individuals from one inbred family: genotype-phenotype correlation and intrafamilial variability. Am J Med Genet 2002; 109: 198201.
  • 20
    Torosyan Y, Aksentijevich I, Sarkisian T, Astvatsatryan V, Ayvazyan A, Centola M, et al. A population-based survey reveals an extremely high FMF carrier frequency in Armenia, suggesting heterozygote advantage [abstract]. Am J Hum Genet 1999; 65 Suppl: A400.
  • 21
    Stoffman N, Magal N, Shohat T, Lotan R, Koman S, Oron A, et al. Higher than expected carrier rates for familial Mediterranean fever in various Jewish ethnic groups. Eur J Hum Genet 2000; 8: 30710.